Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms

Johanna Abelsson, Björn Andréasson, Jan Samuelsson, Malin Hultcrantz, Elisabeth Ejerblad, Berit Johansson, Robyn Emanuel, Ruben Mesa, Peter Johansson

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

The quality of life (QoL) at the time of diagnosis of myeloproliferative neoplasm (MPN) has, to date, not been studied. One hundred and seventy-nine patients with MPN: 80 with essential thrombocythemia (ET), 73 with polycythemia vera (PV), 22 with primary myelofibrosis (PMF) and four with MPN undifferentiated, were included in this study. European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQC30) and the MPN-Symptom Assessment Form (MPN-SAF) were used to evaluate QoL. Fatigue was the most reported symptom in these patients. Patients with PV reported significantly higher mean scores for inactivity, dizziness, cough, itching, depression and lower total QoL compared to patients with ET. Patients with PV had significantly more headache and itching compared to patients with PMF. When the newly diagnosed patients with MPN were compared with a cohort of patients with MPN with mean disease duration of 7.8 years, the differences were most striking for patients with PMF, with significantly more fatigue, abdominal discomfort, concentration problems, insomnia, fever, weight loss and lower overall QoL developed over time.

Original languageEnglish (US)
Pages (from-to)2226-2230
Number of pages5
JournalLeukemia and Lymphoma
Volume54
Issue number10
DOIs
StatePublished - Oct 1 2013

Keywords

  • Essential thrombocythemia
  • Polycythemia vera
  • Primary myelofibrosis
  • Quality of life

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms'. Together they form a unique fingerprint.

  • Cite this

    Abelsson, J., Andréasson, B., Samuelsson, J., Hultcrantz, M., Ejerblad, E., Johansson, B., Emanuel, R., Mesa, R., & Johansson, P. (2013). Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms. Leukemia and Lymphoma, 54(10), 2226-2230. https://doi.org/10.3109/10428194.2013.766732